Document Detail

Chronic eosinophilic leukemia with erythroblastic proliferation and the rare translocation t(8;9)(p22;p24) with PCM1-JAK2 fusion gene: a distinct clinical, pathological and genetic entity with potential treatment target?
MedLine Citation:
PMID:  22288769     Owner:  NLM     Status:  MEDLINE    
Monika Prochorec-Sobieszek; Barbara Nasiłowska-Adamska; Katarzyna Borg; Izabella Kopeć; Kinga Kos-Zakrzewska; Przemysław Juszczyński; Krzysztof Warzocha
Related Documents :
2565279 - Immunoglobulin secretion by isolated intestinal lymphocytes: spontaneous production and...
6968189 - Immune condition in patients with hodgkin's disease.
3742879 - Cell-mediated immunity in anorexia nervosa.
12439609 - Therapeutic vaccination against metastatic renal cell carcinoma by autologous dendritic...
6195589 - Neutrophil and t lymphocyte characteristics of two patients with hyper-ige syndrome.
10540959 - Phenotypic analysis of peripheral lymphocyte subpopulations in hydatid patients.
21902889 - Retrospective epidemiological study of latin american patients with transfusional hemos...
24354099 - Hyperventilation and seizures in an adolescent female.
18974699 - The role of duplex ultrasonography in the diagnosis of lower-extremity deep vein thromb...
Publication Detail:
Type:  Case Reports; Letter     Date:  2012-03-13
Journal Detail:
Title:  Leukemia & lymphoma     Volume:  53     ISSN:  1029-2403     ISO Abbreviation:  Leuk. Lymphoma     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-08-09     Completed Date:  2013-01-04     Revised Date:  2013-03-26    
Medline Journal Info:
Nlm Unique ID:  9007422     Medline TA:  Leuk Lymphoma     Country:  England    
Other Details:
Languages:  eng     Pagination:  1824-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antineoplastic Agents / therapeutic use
Cell Proliferation
Chromosomes, Human, Pair 8 / genetics
Chromosomes, Human, Pair 9 / genetics
Chronic Disease
Diagnosis, Differential
Erythroblasts / pathology*
Hydroxyurea / therapeutic use
Hypereosinophilic Syndrome / diagnosis*,  drug therapy
Infant, Newborn
Interferon-alpha / therapeutic use
Oncogene Proteins, Fusion / genetics*
Pregnancy Complications, Hematologic / diagnosis,  drug therapy,  genetics
Pregnancy Complications, Neoplastic / diagnosis,  drug therapy,  genetics
Translocation, Genetic*
Treatment Outcome
Young Adult
Reg. No./Substance:
0/Antineoplastic Agents; 0/Interferon-alpha; 0/Oncogene Proteins, Fusion; 0/PCM1-JAK2 fusion protein, human; 127-07-1/Hydroxyurea

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Local administration of insulin-like growth factor-I (IGF-I) stimulates tendon collagen synthesis in...
Next Document:  Effect of local exposure to inhomogeneous static magnetic field on stomatological pain sensation - a...